Jeevan Rekha gets permission for Sanofi vaccine trials

July 15, 2021 08:31 pm | Updated July 16, 2021 12:27 am IST - Belagavi

Belagavi-based Jeevan Rekha Hospital has obtained the Union government’s permission to conduct safety and efficacy trials of Sanofi COVID-19 vaccine, developed by a French company.

Jeevan Rekha has been part of the trials of Covaxin and ZyCov-D vaccines.

Trials for the new vaccine will start in 10 days, hospital director Amit Bhate told journalists in Belagavi on Thursday.

Those aged above 18 and who are not vaccinated will be urged to volunteer for vaccine trials.

According to him, Sanofi will be tested in 13 countries. In India, the vaccine will undergo trials in 10 hospitals.

According to hospital sources, over 1,000 people underwent trials for Covaxin. As many as 20 children aged less than 18 underwent trials for Zydus Cadila’s ZyCov-D vaccine.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.